Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1987-8-17
pubmed:abstractText
Expression of the retroviral vector Neor myeloproliferative sarcoma virus (MPSV), which contains the v-mos oncogene and the neomycin resistance gene, leads to neoplastic transformation of mouse fibroblasts. Murine recombinant gamma interferon (IFN-gamma) could revert the neoplastic properties of established Neor MPSV-transformed cell lines to an apparently untransformed phenotype. In the presence of IFN-gamma, the Neor MPSV transformants showed a greater than 97% reduction of cloning efficiency in soft agar, strongly reduced proliferative capacity, and morphological changes. The IFN-gamma-induced phenotypic reversion was preceded by a rapid and selective reduction of all retroviral RNA species, apparently due to IFN-gamma action on the long terminal repeat of Neor MPSV. The mRNA levels of cellular genes either remained unaffected (beta-actin) or were even enhanced (H-2) in IFN-gamma-treated Neor MPSV-transformed cells. Upon removal of IFN-gamma, retroviral gene expression was fully recovered and a gradual reappearance of the transformed phenotype of these cells within 3 weeks was noted. These data show that IFN-gamma can cause a virtually complete, but reversible, inhibition of v-mos-induced neoplastic properties in transformed fibroblasts by selective down regulation of retroviral RNA levels.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-14187925, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-2410953, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-2418130, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-2578626, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-2581554, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3014049, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3016718, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3832070, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3856253, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3881681, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3935435, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3970704, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-3973979, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-4075396, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-518835, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6084313, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6185955, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6190765, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6195895, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6200112, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6204950, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6206644, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6243788, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6251235, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6271971, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6278432, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6288258, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6312838, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6328001, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6332315, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6537818, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6575385, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6584908, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-6893015, http://linkedlifedata.com/resource/pubmed/commentcorrection/3037117-7432471
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2567-72
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't